Decreased Hypothalamo-Pituitary-Adrenal Axis Response to Neuroendocrine Challenge under Repeated Endotoxemia

NeuroImmunoModulation

Volumn 3, Issue 1, 1996, Pages 62-68

  Hadid, Rafi ^a   Spinedi, Eduardo ^b   Giovambattista, Andres ^b   Chautard, Thierry ^a   Gaillard, Rolf C ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Instituto Multidisciplinario de Biologia Celular   (Argentina)

Author keywords

ACTH; Glucocorticoids; Hypoglycemia; Lipopolysaccharide; Tumor necrosis factor

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029782467     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097228     Document Type: Article

References (34)

1. Bateman A. Singh A. Krai T. Solomon S: The immune-hypothalamic-pituitary-adrenal axis. EndocrRev 1989:10:92-112.
2. Buzzetti R. McLoughlin L. Scavo D. Rees LH: A critical assessment of the interactions between the immune system and the hypothala-mo-pituitarv-adrcnal axis. J Endocrinol 1989: 120:183-187.
3. Spinedi E. Sucscun MO. Hadid R. Davcna T. Gaillard RC: Effects of gonadcctomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: Evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992:131:2430-2436.
4. Naito Y. Fukata J. Nakaishi S. Nakai Y. Hirai Y. Tamai S. Mori K. Imura H: Chronic effects of interleukin-1 on hypothalamus, pituitary and adrenal glands in rat. Neuroendocrinology 1990:51:637-641.
5. Sweep CGJ. Van der Mcer MJM. Ilermus ADRMM. Smals AGH. Van der Meer JWM. Pesman GJ. Willemscn SJ. Benraad TJ. Kloppcnborg PWC: Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-lb infusion: In vivo and in vitro studies. Endocrinology 1992; 130:1153-1164.
6. Mcngozzi M, Ghczzi P: Defective tolerance to the toxic and metabolic effects of interleukin I. Endocrinology 1991:128:1668-1672.
7. Evans GF, Zuckcrman SH: Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharidc tolerance. Eur J Immunol 1991;21:1973-1979
8. Bcscdovsky II. Del Rev A. Sorkin E. Dinarcl-lo CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986:233:652-654.
9. Dallman MF. Jones MT: Corticosteroid feedback control of ACTM secretion: effects of stress-induced corticosterone secretion on subsequent stress responses in the rat. Endocrinology 1973:9:1367-1375.
10. Young EA. Akil II: Paradoxical effects of corticosteroids on pituitary ACTH/beta endorphin release in stressed rats. Psychoneuroendocri-nology 1988:13:317-323.
11. Hadid R. Spinedi E. Daneva T. Grau G. Gaillard RC: Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy. Ncuroendocrinologv 1995:62:348-355.
12. Daneva T. Spinedi E. Hadid R. Gaillard RC: Impaired hypothalamo-pituitary-adrenal axis function in Sw iss nude athvmic mice. Ncurocn-docrinologv 1995:62:79-86.
13. Spinedi E. Giacomini M. Jacquicr M-C. Gaillard RC: Changes in the hypothalamo-cortico-trope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinologv 1991, 53: 160-170.
14. Hauger RL. Thrivikraman KV. Plotskv PM: Age-related alterations ol hypothalamic-pitu-itary-adrenal axis function in male Fischer 344 rats. Endocrinology 1994:134:1528-1536.
15. Grau GE. Taylor TE. Molyncux ME. Wirima JJ. Vassalli P. Hommel M. Lambert PH: Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989:320:1586-1591.
16. Zar JH: Bioslatistical Analysis. Englewood Cliffs. Prentice-Hall. 1974.
17. Spinedi E. Hadid R. Daneva T. Gaillard RC: Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 1992:56:46-53.
18. Darling G. Goldstein DS. Stull R. Gorschboth CM. Norton JA: Tumor necrosis factor: immune endocrine interaction. Surgery 1989:106: 1155-1160.
19. Fraker DL, Stovroff MC, Merino MJ, Norton JA: Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 1988:168:95-105.
20. Grunfcld C. Wilking H. Ncese R. Gavin LA. Moser AH. Gulli R. Scrio MK. Feingold KR: Persistence of the hypcrtriglyccridcmic effect of tumor necrosis factor despite development of tachyphylaxis to its anorcctic/cachcctic effects in rats. Cancer Res 1989:49:2554-2560.
21. Sochcr SH. Friedman A. Martinez D: Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med 1988; 167:1957-1962.
22. Uehara A, Sekiya C, Takasugi Y, Namiki M, Arimura A: Anorexia induced by interleukin-1: Involvement of corticotropin-releasing factor. Am J Physiol 1989:257:R613-R617.
23. van der Meer MJM, Fred Sweep CGJ, Pesman GJ, Borm GF, Hermus RMM: Synergism between IL-I bctaandTNFalfaon the activity of the pituitary-adrenal axis and on food intake of rats. Am J Physiol 1995;268:H551-E557.
24. Kancko M. Hiroshige T. Shinsako J. Dallman MF: Diurnal changes in amplification of hormone rhythms in the adrenocortical system. Am J Physiol 1980;239:R309-R316.
25. Sharp BM. Malta SG. Peterson PK. Newton R. Chao C. Mcaltcn K: Tumor necrosis factor-alpha is a potent ACTH secretagoguc: comparison to interleukin-1 beta. Endocrinologv 1989; 124:3131-3133.
26. Sapolskv R, Rivicr C, Yamamoto G, Plotskv P, Vale W; Interleukin-1 stimulates the secretion of hypothalamic corticotropin-rclcasing factor. Science 1987:238:522-524.
27. Barbanel G. Ixart G. Szafarczyk A. Vlalaval F. Assenmachcr I: Intrahypothalamic infusion of interleukin-1 beta increases the release of corticotropin-releasing hormone (CRH 41) and adrenocorticotropic hormone (ACTH) in free-moving rats bearing a push-pull cannula in the median eminence. Brain Res 1990:516:31-36.
28. Wahl SM. Altman LC. Rosentreieh DL: Inhibition of in vivo lymphokine synthesis by glucocorticoids. J Immunol 1975:115:476-481.
29. Beutlcr B. Krochin N. Milsark IW. Luedke C. Cerami A: Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986:232:977-979.
30. Seeman TE. Robbins RJ: Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994:15:233-260.
31. Elenkov IJ. Kovacs K. Kiss J. Belok L. Vizi ES: Lipopolysaccharidc is able to bypass cortico-trophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesions of the paraventricular nucleus. J Endocrinol 1992:133:231-236.
32. Dinarcllo CA. Cannon JG. Wolff SM. Bemheim HA. Beutlcr B. Cerami A. Figari IS. Pal-ladino MA Jr. O'Connor JV: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986:163:1433-1450.
33. Dinarcllo CA: Role of interleukin-1 in infectious diseases. Immunol Today 1992;7:45-56.
34. Potsiaka DD. Clark BD. Vannicr E. Callahan MV. Dinarcllo CA: Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 1991:78:1275-1281.